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Is Depression a Risk Factor for Peripheral Arterial
Disease? Insights from the Heart and Soul Study
Marlene Grenon, Hade Hiramoto, Eric Vittinghoff, Mary
Whooley, Beth Cohen. UCSF, San Francisco, CA
Objectives: Risk factors for peripheral artery disease
(PAD) are tightly linked to those for coronary artery disease
(CAD). Although depression is known to increase risk of
CAD, fewer studies have evaluated depression and PAD.
We examined the association of depression with prevalent
PAD and with prospective PAD events, and evaluated
potential mediators of these associations.
Methods: We used data from the Heart and Soul Study,
a prospective cohort of 1024 men and women with CAD
recruited in 2000-2002 and followed for a mean of 7.2 years.
Depression was assessed with the validated nine-item Patient
Health Questionnaire. Prevalent PAD at baseline was deter-
mined by self-report. Prospective PAD events were adjudi-
cated based on physician diagnosis, radiological imaging
and/or need for PAD surgery. We used logistic and Cox
models to estimate the independent associations of depression
with prevalent PAD at baseline and subsequent PAD events,
adjusting for potential mediators of these associations.
Results: At baseline, depression affected 19% of pa-
tients. Prevalent PAD was reported by 12.1% of patients
with depression and 7.3% of those without (age-adjusted
OR 1.79, 95% CI 1.06-3.03, P.03). In age-adjusted
models, physical inactivity, diabetes, and CRP level each
explained more than 5% of the association between depres-
sion and prevalent PAD. During follow-up, PAD events
occurred in 9% of patients with depression and 6% of those
without (age-adjusted HR 1.77, 95% CI 1.02-3.07,
P.04). Factors explaining more than 5% of the association
between depression and incident PAD events included
inactivity, diabetes, prevalent PAD, race/ethnicity, smok-
ing, HDL, and triglyceride levels.
Conclusions: Depression was associated with a greater
risk of PAD, providing evidence that depression is an
important risk factor for the development of PAD. Since
elevations in traditional, modifiable cardiovascular risk fac-
tors partially explain these associations, such risk factors
should be assessed and aggressively treated.
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In Vivo Assessment of Endothelial Function in Human
Lower Extremity Arteries
Vikram S. Kashyap1, Ryan O. Lakin1, Lindsay Feiten2, Paul
Bishop2, Timur P. Sarac2. 1UniversityHospitals CaseMedical
Center, Cleveland, OH; 2Cleveland Clinic, Cleveland, OH
Objectives: Endothelial function has been measured in
human brachial and coronary arteries, but not in lower
extremity arteries affected by atherosclerosis. We describe a
novel, first-in-man, evaluation of endothelial function in
patients with peripheral arterial disease (PAD) of the super-
ficial femoral arteries (SFA).
Methods: Patients with PAD (n25) requiring lower
extremity angiography were enrolled. Endothelial depen-
dent relaxation (EDR) was measured using intravascular
ultrasound and a Doppler Flow wire after acetylcholine
infusion (Ach). IVUS derived virtual histology (IVUS-VH)
of the same vessel was calculated. Endothelial independent
relaxation (EIR) was measured with infusion of nitroglyc-
erin (NTG, 200 ug).
Results: Patients (mean age 62, 48% male) had a
history of hypertension (80%), coronary disease (32%), and
diabetes (56%). Themean SFA diameter was 5.20.99mm
(range 3.2-6.9 mm). EDR increased over baseline for all
patients with Ach infusion 10-6-10-4. Diameter (0.5% at
Ach10-4) and area (1.83% at Ach10-4) changes in the
diseased SFA were modest. But, average velocity of blood
flow (APV) significantly increased 26.2, 46 and 63% with
Ach infusion 10-6-10-4. Calculations of blood flow
(mm2/sec, 67% change, Ach10-4) and limb volume flow
(mm3/sec, 68.1%, Ach10-4) were performed. Lower ex-
tremity NOx levels approximated systemic venous levels
(P.6). NTG infusion indicated normal smooth muscle
responsiveness (3.3% diameter, 8.9% area, and 116% veloc-
ity change over baseline). IVUS-VH plaque stratification
indicated predominantly fibrous morphology (45.5%; ne-
crotic core, 28.9%; calcium, 18.2%). Atheroma burden was
14.89 5.5 mm3/cm and did not correlate with endothe-
lial responsiveness.
Conclusions: Endothelial function can be measured
directly in human lower extremity arteries. Despite exten-
sive atherosclerosis, endothelial function is still intact.
These data support the application of regional endothelial-
specific biological therapies in patients with PAD.
Author Disclosures: P. Bishop: Nothing to disclose; L.
Feiten: Nothing to disclose; V. S. Kashyap: NIH, AVA,
Research Grants; R. O. Lakin: Nothing to disclose; T. P.
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Primary Angiosarcoma of the Aorta and Great Vessels
Javairiah Fatima, Audra A. Duncan, Gustavo S. Oderich,
Peter Gloviczki, Manju Kalra, McKusick Michael, Thomas
C. Bower. Mayo Clinic, Rochester, MN
Objectives: Primary angiosarcomas originating from
the heart, aorta or the great vessels are extremely rare, and
hence poorly understood. We reviewed our experience to
identify a preferred diagnostic and treatment strategy, and
evaluate role of adjunctive therapy.
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